MD Biosciences is a leading discovery and clinical-stage pharmaceutical and biotechnology company offering sophisticated research services, innovative bioproducts and advanced diagnostic capabilities. Our 25+ year history of unparalleled scientific expertise and proprietary methodologies in the inflammatory and neurology landscapes have positioned us at the forefront of the precision medicine movement.